Equities

OpGen Inc

OpGen Inc

Actions
  • Price (USD)1.81
  • Today's Change-0.18 / -9.05%
  • Shares traded5.34k
  • 1 Year change-55.85%
  • Beta-0.5547
Data delayed at least 15 minutes, as of Nov 21 2024 20:03 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
MEI Pharma Inc0.00-46.60m18.66m28.00--0.7499-----6.99-6.990.003.730.00----0.00-72.25-21.09-79.28-23.99-------72.23----0.00--33.7667.75155.84---49.68--
Mira Pharmaceuticals Inc0.00-11.24m18.70m3.00--5.76-----0.7287-0.72870.000.21970.00----0.00-169.22---191.76-------------3.320.00-------69.77------
Kairos Pharma Ltd0.00-2.74m18.75m----5.63-----0.2279-0.22790.000.25940.00-------92.10---264.70-------------2.610.0409-------72.57------
Neurosense Therapeutics Ltd0.00-7.51m19.28m16.00---------0.4392-0.43920.00-0.09430.00----0.00-154.72---470.03----------------------18.10------
Unity Biotechnology Inc0.00-19.05m19.71m19.00--1.39-----1.14-1.140.000.83940.00----0.00-32.73-47.21-38.49-53.51-------6,395.92----0.00---100.00--10.36---61.28--
Forte Biosciences Inc0.00-34.20m19.79m11.00--2.11-----20.00-20.000.006.420.00----0.00-103.90-72.06-137.40-82.27-------491,850.00----0.00-------126.79---46.29--
Goldenwell Biotech Inc940.00-137.11k19.80m----5,169.71--21,063.83-0.0014-0.00140.000010.000040.00480.0031-----69.82---70.29--42.55---14,586.17--21.43--0.00---95.10--88.13------
Ibio Inc175.00k-14.36m20.01m16.00--1.07--114.35-3.97-6.650.03072.060.0056----10,937.50-46.17-27.69-75.53-33.13-----8,204.57-1,862.11----0.0736-----35.5247.31---26.66--
OpGen Inc1.96m-22.39m20.04m100.00------10.20-20.01-20.011.66-8.650.1553--6.09---176.99-87.95-15,455.17-127.653.1515.42-1,139.66-794.78---20.25----31.113.0212.38--40.20--
Spruce Biosciences Inc7.10m-39.43m20.24m22.00--0.3919--2.85-0.9598-0.95980.17281.250.0798----244,862.10-44.28-41.24-55.51-46.49-----555.23-1,774.39---121.120.0399-------3.77------
Pulmatrix Inc10.01m-9.66m20.53m22.00--1.88--2.05-2.64-2.642.742.990.4145--23.16454,772.70-40.00-46.91-44.64-58.12-----96.51-238.04----0.00--20.21116.6225.03--104.29--
Neurobo Pharmaceuticals Inc0.00-27.73m20.68m8.00--1.60-----4.77-4.770.001.500.00----0.00-114.20-95.57-159.68-135.64------------0.00------10.72--75.54--
Cocrystal Pharma Inc0.00-18.70m20.96m12.00--1.65-----1.84-1.840.001.250.00----0.00-76.57-50.94-83.17-52.77-------1,501.78----0.00------53.69--33.34--
Pieris Pharmaceuticals Inc1.35m-15.95m21.14m46.00--1.30--15.63-12.61-12.611.0612.320.0338--1.9129,391.30-39.93-28.41-68.21-39.69-----1,179.96-94.61----0.00--65.288.0326.25---36.82--
GlycoMimetics Inc10.00k-39.74m21.28m35.00--1.87--2,127.97-0.6165-0.61650.00020.17640.0003--0.0836285.71-115.34-43.60-136.58-47.82-----397,350.50-2,243.52----0.00---86.67--20.97---29.82--
Data as of Nov 21 2024. Currency figures normalised to OpGen Inc's reporting currency: US Dollar USD

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Edward D. Jones & Co. LP (Investment Management)as of 30 Sep 20243.000.00%
Tower Research Capital LLCas of 30 Sep 20240.000.00%
UBS Securities LLCas of 30 Sep 20240.000.00%
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 30 Sep 20240.000.00%
RBC Dominion Securities, Inc. (Investment Management)as of 30 Sep 20240.000.00%
NewEdge Advisors LLCas of 30 Sep 20240.000.00%
Qube Research & Technologies Ltd.as of 30 Sep 20240.000.00%
Bank of America, NA (Private Banking)as of 30 Sep 20240.000.00%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.